Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin in Bulimia Nervosa
NCT00304187Phase 2Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2004
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erythromycin in bulimia nervosa (BN), sponsored by New York State Psychiatric Institute. Started Sep 2004; status: completed.
02
Drugs
erythromycin
03
Conditions
bulimia nervosa (BN)
Beyond the preview
Go deeper on NCT00304187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304187.